Get Quotes

Market Menu

INCOME STATEMENTS-Aarey Drugs & Pharmaceuticals Ltd.

You can view the income statements for the last 5 years.

BSE

Nov 28, 04:01
37.50 -0.40 ( -1.06%)
Volume 11953
Prev. Close 37.90
Open Price 37.15
Today's Low / High
37.15
     
38.50
Bid Price(Qty.) 0.00 (0)
Open Pr.(Qty.) 0.00 (0)
52 Wk Low / High
28.50
     
64.40

NSE

Nov 28, 03:47
37.75 +0.00 (+ 0.00%)
Volume 23352
Prev. Close 37.75
Open Price 37.85
Today's Low / High
37.50
     
38.50
Bid Price(Qty.) 0.00 (0)
Open Pr.(Qty.) 37.75 (1)
52 Wk Low / High
28.25
     
64.35
ISIN No INE198H01019 Market Cap. ( Rs. in Cr. ) 95.83 P/BV 0.84 Book Value ( Rs. ) 44.77
BSE Code 524412 52 Week High/Low ( Rs. ) 64/28 FV/ML 10/1 P/E(X) 14.64
NSE Code AAREYDRUGSEQ Book Closure 30/09/2019 EPS ( Rs. ) 2.58 Div Yield (%) 0.00
( Rs. in Crs. )
ParticularsMar 22Mar 21Mar 20Mar 19Mar 18
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]492.68348.42300.09354.74349.35
Total Operating Revenues492.68348.42300.09354.74349.35
      
Other Income2.757.016.694.343.18
Total Revenue495.43355.43306.78359.08352.53
      
EXPENSES     
Purchase Of Stock-In Trade467.29339.25285.93347.45346.93
Changes In Inventories Of FG,WIP And Stock-In Trade4.78-1.464.25-6.48-9.56
Employee Benefit Expenses0.980.400.400.470.38
Finance Costs2.002.431.792.231.92
Depreciation And Amortisation Expenses1.990.920.891.010.71
Other Expenses8.375.596.285.413.96
Total Expenses485.40347.13299.54350.09344.34
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax10.038.307.248.998.19
      
Profit/Loss Before Tax10.038.307.248.998.19
      
Tax Expenses-Continued Operations     
Current Tax2.611.661.502.252.25
Deferred Tax-0.110.12-0.050.19-0.24
Tax For Earlier Years0.980.000.000.000.00
Total Tax Expenses3.481.791.452.442.01
Profit/Loss After Tax And Before ExtraOrdinary Items6.546.515.796.546.18
      
Profit/Loss From Continuing Operations6.546.515.796.546.18
      
Profit/Loss For The Period6.546.515.796.546.18
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)2.722.792.482.802.64
Diluted EPS (Rs.)2.722.792.802.802.64
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend0.000.000.000.230.00
Equity Dividend Rate (%)0.000.000.001.000.00
ParticularsMar 22
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]492.68
Total Operating Revenues492.68
Other Income2.75
Total Revenue495.43
EXPENSES 
Purchase Of Stock-In Trade467.29
Changes In Inventories Of FG,WIP And Stock-In Trade4.78
Employee Benefit Expenses0.98
Finance Costs2.00
Depreciation And Amortisation Expenses1.99
Other Expenses8.37
Total Expenses485.40
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax10.03
Profit/Loss Before Tax10.03
Tax Expenses-Continued Operations 
Current Tax2.61
Deferred Tax-0.11
Tax For Earlier Years0.98
Total Tax Expenses3.48
Profit/Loss After Tax And Before ExtraOrdinary Items6.54
Profit/Loss From Continuing Operations6.54
Profit/Loss For The Period6.54
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)2.72
Diluted EPS (Rs.)2.72
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend0.00
Equity Dividend Rate (%)0.00